Teva Picks Vigodman as CEO Amid Restructuring

Teva Picks Vigodman as CEO Amid Restructuring Play

Jan. 9 (Bloomberg) -- Teva Pharmaceutical chose board member Erez Vigodman as chief executive officer of the world’s biggest generic-drug maker after the previous CEO left in a dispute with the board. Elliott Gotkine has more on Bloomberg Television's "Countdown." (Source: Bloomberg)

blog comments powered by Disqus